The phrase "availability of mutations" is correct and usable in written English.
It can be used in contexts discussing genetics, biology, or evolution, particularly when referring to the presence or occurrence of mutations in a population or organism.
Example: "The availability of mutations in the gene pool can significantly impact the adaptability of a species to changing environments."
Alternatives: "presence of mutations" or "occurrence of mutations".
The availability of mutations is just one of many factors, some internal and some external, that can determine or block the path to domestication in different species.
The public availability of mutations covering most of the Drosophila genome is also conducive to rapid screening for novel loci that modulate the physiological response to exercise.
The rationale for the substrate-envelope constraint is that it prevents designed inhibitors from making interactions beyond those required by substrates and thus limits the availability of mutations tolerated by substrates but not by designed inhibitors.
The availability of mutations in at least 75 of these genes will allow a detailed investigation into the modulatory role of this important class of peptides in C. elegans behavior.
(The mutation detection rate for DMD patients from this institution is 97% indicating that there is negligible bias in patient selection based on the availability of mutation data).
The relationship between the clinical severity of OI and the causative mutations is only partially understood, despite the availability of mutation sequences from >800 individuals with OI (5).
The explosion in the availability of mutation data, resulting from the application of SNP chips [ 1] and next-generation sequencing [ 2] has led to a huge demand to analyze and predict the effects of mutations.
The prognostic relevance of these downstream mutations in CRC has been investigated for decades with inconsistent results but has attracted increasing focus lately as a consequence of the collection of prospective clinical data and availability of mutation status in larger cohorts.
The availability of existing mutations will enable more accurate assessments of mutation frequency such as noncomplementation screens (Greenwald and Horvitz 1980).
This means that the fate of each beneficial mutation depends on many parameters: mutation rate, population size, and the distribution of fitness effects all control the availability of competing mutations that can help or hinder the spread of each new beneficial mutation (G errish and L enski 1998; W ilke 2004; D esai and F isher 2007; F ogle et al. 2008; R ouzine et al. 2008).
The Harms paper showed that biophysical requirements dictate the limited availability of permissive mutations.
